100th つないで、進む FRONTIERS IN LIFE SCIENCE

検索の使い方

Lung Squamous Cell Carcinoma And Adjacent Normal Tissue Array, Including TNM, Clinical Stage And Pathology Grade, 50 Cases/100 Cores, Replacing BC04118|ヒト組織アレイ

掲載日情報：2016/03/01 現在Webページ番号：179022

ティッシューアレイドットコム /
TissueArray.Com LLC
[メーカー略称：USB]

US Biomax社は、組織アレイを提供しているメーカーです。
US Biomax社のヒト組織アレイ(Lung Squamous Cell Carcinoma And Adjacent Normal Tissue Array, Including TNM, Clinical Stage And Pathology Grade, 50 Cases/100 Cores, Replacing BC04118)をご紹介します。

※ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
※ドナーの組織は、HIVおよびHepatitis Bが陰性であることを確認しています。
※本製品は研究用です。研究用以外には使用できません。

カートに商品を
追加しました。

ヒト組織アレイの価格

[在庫・価格 ：2025年04月29日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
 納期 文献数
Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50・・・
  • メーカーサイト
  • お問い合わせ
 2～3週間 ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0
  • メーカーサイト
  • お問い合わせ
説明文
法規制等
保存条件 4℃ 法規備考
掲載カタログ

製品記事 TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド
関連記事 TissueArray.Com社 パラフィン組織スライド／組織アレイの仕様変更につきまして

[在庫・価格 ：2025年04月29日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50・・・

文献数： 0

  • メーカーサイト
  • お問い合わせ

説明文
法規制等
保存条件 4℃ 法規備考
掲載カタログ

製品記事 TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド
関連記事 TissueArray.Com社 パラフィン組織スライド／組織アレイの仕様変更につきまして
  • メーカーサイト
  • お問い合わせ

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイの特長

Microarray Panel: Lung squamous cell carcinoma and adjacent normal tissue microarray, containing 50 cases of each squamous cell carcinoma and matched adjacent normal tissue, duplicate cores per case
Cores: 100
組織アレイ
Cases: 50
Layout: 10 cols × 10 rows
Core Diameter: 1 mm
Thickness: 5 µm
Quality Control: H&E and IHC confirmed
Applications:

Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes: 1. TMA slides were sectioned and stored at 4C, may not be fresh cut. Please request fresh cut if experiment involves phosphor-specific antibodies, FISH or ISH, etc., minimal 3 slides be purchased of each TMA apllies to cover the cost of trimming for the fresh sectioning.
2. Most of TMA slides were not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), but it is still recommended 30 min. of baking at 60C before putting into xylene for de-paraffinization procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 F 43 Lung Squamous cell carcinoma 1 IIB T2N1M0 Malignant
A2 2 M 45 Lung Squamous cell carcinoma 1 IIIA T2N2M0 Malignant
A3 3 M 46 Lung Squamous cell carcinoma 1 I T2N0M0 Malignant
A4 4 M 53 Lung Squamous cell carcinoma 1 IIB T2N1M0 Malignant
A5 5 M 66 Lung Squamous cell carcinoma 1 IB T2N0M0 Malignant
A6 6 F 60 Lung Squamous cell carcinoma 1 IIB T2N1M0 Malignant
A7 7 M 68 Lung Squamous cell carcinoma 1 IIB T2N1M0 Malignant
A8 8 M 51 Lung Squamous cell carcinoma with necrosis (sparse) – IIB T2N1M0 Malignant
A9 9 M 62 Lung Squamous cell carcinoma 2 IIIA T3N2M0 Malignant
A10 10 M 70 Lung Squamous cell carcinoma 2 IIB T3N0M0 Malignant
B1 11 M 55 Lung Squamous cell carcinoma 1 IIB T2N1M0 Malignant
B2 12 M 54 Lung Squamous cell carcinoma 1 IB T2N0M0 Malignant
B3 13 M 65 Lung Squamous cell carcinoma with necrosis 1 IB T2N0M0 Malignant
B4 14 M 64 Lung Squamous cell carcinoma 1 IB T2N0M0 Malignant
B5 15 M 48 Lung Squamous cell carcinoma 1 IIB T2N1M0 Malignant
B6 16 M 58 Lung Squamous cell carcinoma 1 IIB T2N1M0 Malignant
B7 17 M 69 Lung Squamous cell carcinoma – IIB T2N1M0 Malignant
B8 18 M 62 Lung Squamous cell carcinoma 2 IIB T2N1M0 Malignant
B9 19 M 30 Lung Squamous cell carcinoma 2 IB T2N0M0 Malignant
B10 20 M 77 Lung Squamous cell carcinoma 2 IIB T2N1M0 Malignant
C1 21 M 72 Lung Squamous cell carcinoma 2 IIB T2N1M0 Malignant
C2 22 M 48 Lung Squamous cell carcinoma 2 IIB T2N1M0 Malignant
C3 23 M 59 Lung Squamous cell carcinoma 2 IB T2N0M0 Malignant
C4 24 M 64 Lung Squamous cell carcinoma 2 IIB T3N0M0 Malignant
C5 25 M 69 Lung Squamous cell carcinoma 2 IB T2N0M0 Malignant
C6 26 M 46 Lung Squamous cell carcinoma – IIIA T3N1M0 Malignant
C7 27 M 57 Lung Squamous cell carcinoma 2 IIB T2N1M0 Malignant
C8 28 M 54 Lung Squamous cell carcinoma 2 IIB T3N0M0 Malignant
C9 29 M 64 Lung Squamous cell carcinoma 2 IIB T2N1M0 Malignant
C10 30 M 53 Lung Squamous cell carcinoma 2 IIIA T3N1M0 Malignant
D1 31 M 65 Lung Squamous cell carcinoma 2 IB T2N0M0 Malignant
D2 32 M 54 Lung Squamous cell carcinoma – IIIA T2N2M0 Malignant
D3 33 M 50 Lung Squamous cell carcinoma 2 IIB T2N1M0 Malignant
D4 34 M 55 Lung Squamous cell carcinoma 2 IIIB T4N1M0 Malignant
D5 35 F 52 Lung Squamous cell carcinoma 2 IB T2N0M0 Malignant
D6 36 M 53 Lung Squamous cell carcinoma 2 IB T2N0M0 Malignant
D7 37 M 67 Lung Squamous cell carcinoma 2 IIB T3N0M0 Malignant
D8 38 M 66 Lung Squamous cell carcinoma 2 IB T2N0M0 Malignant
D9 39 F 56 Lung Squamous cell carcinoma 2 IIIA T2N2M0 Malignant
D10 40 F 55 Lung Squamous cell carcinoma – IIB T2N1M0 Malignant
E1 41 F 52 Lung Squamous cell carcinoma 2 IB T2N0M0 Malignant
E2 42 M 63 Lung Squamous cell carcinoma (sparse) 2 IIIA T3N1M0 Malignant
E3 43 M 74 Lung Squamous cell carcinoma 3 IIB T2N1M0 Malignant
E4 44 M 47 Lung Squamous cell carcinoma 3 IIB T3N0M0 Malignant
E5 45 M 55 Lung Squamous cell carcinoma 3 IB T2N0M0 Malignant
E6 46 M 58 Lung Squamous cell carcinoma 3 IB T2N0M0 Malignant
E7 47 M 71 Lung Squamous cell carcinoma 3 IB T2N0M0 Malignant
E8 48 M 50 Lung Squamous cell carcinoma 3 IIIA T4N1M0 Malignant
E9 49 M 52 Lung Squamous cell carcinoma 3 IB T2N0M0 Malignant
E10 50 M 25 Lung Squamous cell carcinoma 3 IB T2N0M0 Malignant
F1 51 F 43 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
F2 52 M 45 Lung Adjacent normal lung tissue – IIIA T2N2M0 NAT
F3 53 M 46 Lung Adjacent normal lung tissue – I T2N0M0 NAT
F4 54 M 53 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
F5 55 M 66 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
F6 56 F 60 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
F7 57 M 68 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
F8 58 M 51 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
F9 59 M 62 Lung Adjacent normal lung tissue – IIIA T3N2M0 NAT
F10 60 M 70 Lung Adjacent normal lung tissue – IIB T3N0M0 NAT
G1 61 M 55 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
G2 62 M 54 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
G3 63 M 65 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
G4 64 M 64 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
G5 65 M 48 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
G6 66 M 58 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
G7 67 M 69 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
G8 68 M 62 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
G9 69 M 30 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
G10 70 M 77 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
H1 71 M 72 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
H2 72 M 48 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
H3 73 M 59 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
H4 74 M 64 Lung Adjacent normal lung tissue – IIB T3N0M0 NAT
H5 75 M 69 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
H6 76 M 46 Lung Adjacent normal lung tissue – IIIA T3N1M0 NAT
H7 77 M 57 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
H8 78 M 54 Lung Adjacent normal lung tissue – IIB T3N0M0 NAT
H9 79 M 64 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
H10 80 M 53 Lung Adjacent normal lung tissue – IIIA T3N1M0 NAT
I1 81 M 65 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
I2 82 M 54 Lung Adjacent normal lung tissue – IIIA T2N2M0 NAT
I3 83 M 50 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
I4 84 M 55 Lung Adjacent normal lung tissue – IIIB T4N1M0 NAT
I5 85 F 52 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
I6 86 M 53 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
I7 87 M 67 Lung Adjacent normal lung tissue – IIB T3N0M0 NAT
I8 88 M 66 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
I9 89 F 56 Lung Adjacent normal lung tissue – IIIA T2N2M0 NAT
I10 90 F 55 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
J1 91 F 52 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
J2 92 M 63 Lung Adjacent normal lung tissue – IIIA T3N1M0 NAT
J3 93 M 74 Lung Adjacent normal lung tissue – IIB T2N1M0 NAT
J4 94 M 47 Lung Adjacent normal lung tissue – IIB T3N0M0 NAT
J5 95 M 55 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
J6 96 M 58 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
J7 97 M 71 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
J8 98 M 50 Lung Adjacent normal lung tissue – IIIA T4N1M0 NAT
J9 99 M 52 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
J10 100 M 25 Lung Adjacent normal lung tissue – IB T2N0M0 NAT
– – M 42 Adrenal gland Pheochromocytoma (tissue marker) – Malignant

*For precise diagnosis, refer to pathology description.

目次に戻る

カートに商品を
追加しました。

ヒト組織アレイのFAQ

US BIOMAX社ヒト組織アレイのFAQはこちら。

目次に戻る

カートに商品を
追加しました。

お問い合わせ先

（テクニカルサポート 試薬担当）

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。